LECRK4 Antibody

What is LECRK4 and why are antibodies against it important for plant immunity research?

LecRK4.1 (Lectin Receptor Kinase 4.1) is a critical component in plant immune signaling pathways, positively regulating pattern-triggered immunity (PTI) in Arabidopsis and contributing to resistance against both biotrophic and necrotrophic pathogens . Antibodies targeting LECRK4 are essential tools for researchers investigating plant-pathogen interactions, allowing for protein detection, localization studies, and analysis of expression patterns during infection processes. Unlike simpler protein targets, receptor kinases like LECRK4 present unique challenges for antibody development due to their transmembrane nature and complex structural domains.

What are the primary applications for LECRK4 antibodies in experimental research?

LECRK4 antibodies serve multiple critical functions in plant immunity research:

• Western Blot Analysis: Detection and quantification of LECRK4 protein levels in different tissues or under various treatment conditions

• Immunoprecipitation (IP): Isolation of LECRK4 and associated protein complexes to study interaction partners

• Immunocytochemistry/Immunofluorescence (ICC/IF): Visualization of LECRK4 subcellular localization

• Flow Cytometry (FCM): Quantitative analysis of LECRK4 expression in cell populations

• Enzyme-Linked Immunosorbent Assay (ELISA): Quantification of LECRK4 in complex samples

Similar to antibodies developed against other targets like CDK4, LECRK4 antibodies can be validated across multiple experimental approaches to ensure reliability and reproducibility of results .

How should researchers select the appropriate LECRK4 antibody for their specific experimental needs?

Selection criteria should include:

• Target specificity: Ability to distinguish LECRK4 from other lectin receptor kinases, particularly those with high sequence homology

• Validated applications: Confirmed utility in intended experimental techniques (Western blot, IP, IHC, etc.)

• Host species compatibility: Ensuring minimal cross-reactivity with the experimental model system

• Epitope location: Considering whether the antibody targets extracellular, transmembrane, or cytoplasmic domains based on research needs

• Monoclonal vs. polyclonal: Selecting based on required specificity and sensitivity demands

When evaluating published literature using LECRK4 antibodies, researchers should critically assess the validation methods employed and replication of results across independent studies .

What are the optimal protein extraction protocols for LECRK4 antibody applications?

LECRK4, being a membrane-associated receptor kinase, requires specific extraction protocols:

• Buffer composition: Use buffers containing 1% non-ionic detergents (Triton X-100 or NP-40) to solubilize membrane proteins without disrupting antibody epitopes

• Protease inhibitors: Include a comprehensive protease inhibitor cocktail to prevent degradation

• Phosphatase inhibitors: Add sodium fluoride (NaF, 10mM) and sodium orthovanadate (Na₃VO₄, 1mM) when studying phosphorylation states

• Temperature control: Maintain samples at 4°C throughout extraction to prevent degradation

• Mechanical disruption: For plant tissues, use bead-beating or grinding in liquid nitrogen to ensure complete cell lysis

These considerations parallel extraction protocols used for other membrane-associated proteins studied in plant immunity research, though specific optimizations may be necessary for different plant tissues or developmental stages .

How can researchers optimize Western blot protocols for LECRK4 detection?

Optimization strategies include:

• Sample preparation: Heat samples at 70°C (not 95°C) for 10 minutes to prevent aggregation of membrane proteins

• Gel percentage: Use 8-10% SDS-PAGE gels for optimal resolution of LECRK4 (approximately 75-80 kDa)

• Transfer conditions: Implement wet transfer at lower voltage (30V) overnight at 4°C for efficient transfer of membrane proteins

• Blocking strategy: Use 5% BSA rather than milk to prevent non-specific binding

• Antibody dilution: Begin with 1:1000 dilution of primary antibody and optimize based on signal-to-noise ratio

• Detection method: Enhanced chemiluminescence (ECL) systems with longer exposure times may be necessary for detecting lower abundance receptor proteins

These recommendations are based on general principles for membrane protein detection and may require experimental refinement based on specific antibody characteristics and sample types .

What validation methods ensure reliable results when using LECRK4 antibodies?

Comprehensive validation should include:

• Positive and negative controls: Use of known LECRK4-expressing tissues and knockout/knockdown lines

• Peptide competition assays: Pre-incubation of antibody with immunizing peptide should abolish specific signal

• Orthogonal techniques: Correlation of protein detection with mRNA expression data from RT-qPCR

• Cross-reactivity testing: Evaluation of potential cross-reactivity with related lectin receptor kinases

• Multiple antibody concordance: Verification with independent antibodies targeting different LECRK4 epitopes

Similar validation approaches have been successfully employed for other plant immunity components, ensuring experimental rigor and reproducibility .

How can LECRK4 antibodies be used to investigate protein-protein interactions in immune signaling pathways?

Advanced methodological approaches include:

• Co-immunoprecipitation (Co-IP):

  • Use LECRK4 antibodies conjugated to magnetic beads or protein A/G

  • Include chemical crosslinking (1-2% formaldehyde for 10-15 minutes) to capture transient interactions

  • Analyze precipitated complexes by mass spectrometry to identify novel interaction partners

• Proximity Ligation Assay (PLA):

  • Combine LECRK4 antibodies with antibodies against suspected interaction partners

  • Visualize interaction events as fluorescent dots using complementary DNA-linked secondary antibodies

  • Quantify interaction frequency under different pathogen challenge conditions

• Bimolecular Fluorescence Complementation (BiFC) validation:

  • Use antibodies to confirm expression levels of fusion proteins

  • Compare interaction patterns observed with BiFC to antibody-based localization studies

These approaches have successfully revealed interactions between various plant immune components, similar to how interactions between TPL and RxL21 were characterized in downy mildew research .

What techniques can researchers employ to study LECRK4 phosphorylation states during immune responses?

Phosphorylation-specific approaches include:

• Phospho-specific antibodies:

  • Development requires identification of key phosphorylation sites through mass spectrometry

  • Validation involves treatment with phosphatases to confirm specificity

  • Use in time-course experiments to track phosphorylation dynamics during infection

• Phos-tag™ SDS-PAGE:

  • Incorporate Phos-tag™ reagent into acrylamide gels to create mobility shifts for phosphorylated proteins

  • Detect with standard LECRK4 antibodies to visualize multiple phosphorylation states

  • Compare patterns before and after pathogen challenge

• Immunoprecipitation-mass spectrometry (IP-MS):

  • Enrich LECRK4 using antibodies before mass spectrometry analysis

  • Map phosphorylation sites and quantify changes in modification abundance

  • Correlate with functional outcomes in immunity

These methodologies parallel approaches used to study post-translational modifications in other plant immunity components, such as those analyzed in the RxL21 effector studies .

How can researchers address non-specific binding issues with LECRK4 antibodies?

Troubleshooting strategies include:

• Optimization of blocking conditions:

  • Test alternative blocking agents (BSA, casein, commercial blocking solutions)

  • Increase blocking time from 1 hour to overnight at 4°C

  • Add 0.1-0.3% Tween-20 to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Perform serial dilutions (1:500, 1:1000, 1:2000, 1:5000) to identify optimal concentration

  • Increase washing steps between antibody incubations (5 x 5 minutes)

  • Prepare antibody dilutions in blocking buffer containing 0.1% Tween-20

• Sample preparation refinement:

  • Additional centrifugation steps to remove insoluble material

  • Pre-clear lysates with Protein A/G beads before antibody application

  • Filter samples through 0.45 μm filters to remove aggregates

These approaches have proven effective when troubleshooting antibody applications for other plant immunity components and membrane proteins .

What strategies can overcome limitations in detecting low-abundance LECRK4 in plant tissues?

Sensitivity enhancement approaches include:

• Signal amplification systems:

  • Biotin-streptavidin detection systems can amplify signal 3-5 fold

  • Tyramide signal amplification (TSA) can increase sensitivity 10-50 fold

  • Quantum dot-conjugated secondary antibodies provide superior signal-to-noise ratio

• Sample enrichment techniques:

  • Subcellular fractionation to concentrate membrane fractions

  • Immunoprecipitation followed by Western blotting for enrichment

  • Concentration of samples using ultrafiltration devices

• Detection optimization:

  • Extended exposure times with highly sensitive CCD camera systems

  • Use of enhanced chemiluminescence (ECL) substrates with extended signal duration

  • Digital stacking of multiple exposures to enhance weak signals

These approaches parallel detection strategies employed for other low-abundance membrane receptors involved in plant immunity pathways .

How can LECRK4 antibodies be utilized in high-throughput screening applications?

Advanced screening methodologies include:

• Antibody arrays:

  • Immobilization of LECRK4 antibodies in microarray format

  • Simultaneous detection of LECRK4 across multiple samples/conditions

  • Quantitative analysis of expression patterns in response to diverse pathogen elicitors

• Automated immunoprecipitation systems:

  • Integration with robotic liquid handling for standardized IP protocols

  • Parallel processing of multiple samples for comparative interactome studies

  • Combination with mass spectrometry for high-throughput protein complex identification

• Flow cytometry applications:

  • Multiparameter analysis combining LECRK4 detection with other immune markers

  • High-throughput screening of plant cell populations under various treatment conditions

  • Cell sorting based on LECRK4 expression levels for downstream analysis

These approaches represent cutting-edge applications of antibody technology in plant immunity research, enabling systems-level analysis of receptor function .

What are the prospects for using LECRK4 antibodies in translational agricultural research?

Translational applications include:

• Pathogen resistance biomarkers:

  • Development of ELISA-based field kits to quantify LECRK4 activation as indicators of plant immunity status

  • Screening of germplasm collections for optimal LECRK4 expression and activation profiles

  • Monitoring effects of agricultural practices on baseline immunity levels

• Precision breeding tools:

  • Antibody-based selection of lines with enhanced LECRK4 expression/function

  • Quality control testing for engineered crops with modified LECRK4 pathways

  • Functional validation of genomic markers linked to disease resistance

• Crop protection development:

  • Screening for compounds that enhance LECRK4-mediated immunity

  • Evaluation of novel elicitors that specifically activate LECRK4 signaling

  • Assessment of pathogen adaptation to LECRK4-mediated defense mechanisms

These applications represent important bridges between fundamental research on lectin receptor kinases and practical agricultural solutions for disease management .